Phase II/III (Integrated)

392 trials 186 recruiting

Filter these 392 trials by condition, country, sponsor and more.

Open in Search →

Study to evaluate the therapeutic effect of a cell based immune therapy targeting cancer stem cells i the malignant brain tumor glioblastoma… Recruiting

2024-518663-35-00 Glioblastoma 2018-04-25
Treatment of Graves´ ophthalmopathy with diclofenak or simvastatin Recruiting

2024-517833-42-00 Graves´ ophthalmopathy 2017-12-11
SIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependym… Recruiting

2024-512222-28-00 Newly diagnosed with an intracranial or spinal ependymo 2015-06-02
rEECur: International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma Recruiting

2024-516078-31-00 Recurrent and Primary Refractory Ewing Sarcoma 2015-05-05
PEHRICCA : PErioperative CISGEM plus RILVEGOSTOMIG in High-Risk resectable Intrahepatic CholangioCarcinoma Ended

2025-521302-17-00 Hihg risk of cholangiocarcinoma intra hépatic resectabl 2026-05-26
Phase 3 trial aimed at improving the overall survival of AML in adults aged 18 to 60 by comparing high-dose idarubicin with daunorubicin at … Ended

2024-516873-57-00 Acute myeloid leukemia in adults aged 18 to 60 2026-01-13
A study of BMS-986504 in combination with Nab-p/Gem versus placebo in combination with Nab-p/Gem in untreated metastatic PDAC with homozygou… Ended

2025-522598-12-00 Untreated Metastatic Pancreatic Ductal Adenocarcinoma 2025-12-17
Phase II-III study to assess the efficacy and safety of sublingual immunotherapy in patients suffering from grass pollen allergy Ended

2024-517524-18-00 Patients with moderate-to-severe allergic rhinitis / rh 2025-10-22
Phase II-III study to assess the efficacy and safety of subcutaneous cluster-immunotherapy in patients suffering from grass pollen allergy Ended

2024-517521-25-00 Patients with moderate-to-severe allergic rhinitis/rhin 2025-10-20
A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF Ended

2025-520809-12-00 Diabetic Macular Edema 2025-10-16
Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent Glioblastoma (GBM) Ended

2024-511452-40-00 Oncology - Glioblastoma (GBM) 2025-09-12
A clinical study of tulisokibart in people with hidradenitis suppurativa (MK-7240-012) Ended

2024-520039-33-00 Hidradenitis Suppurativa 2025-08-11
Phase II-III study to assess the efficacy and safety of subcutaneous cluster-immunotherapy in patients suffering from birch pollen allergy Ended

2024-517515-75-00 Patients with moderate-to-severe allergic rhinitis / rh 2025-07-17
A Global, Randomized, Open-label, Multicenter, Phase 2b/3 Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatit… Ended

2024-519063-18-00 Chronic Hepatitis Delta Infection 2025-06-24
A clinical study of raludotatug deruxtecan in people with gastrointestinal cancers (MK-5909-005) Ended

2024-517416-30-00 Gastrointestinal Cancers 2025-03-31
A study to learn if a combination of Fianlimab and Cemiplimab versus Cemiplimab alone is more effective for adult participants with Advanced… Ended

2022-501483-18-00 Advanced Non-Small Cell Lung Cancer 2025-03-28
A follow-up trial of GBS NN/NN2 vaccine in healthy pregnant women Ended

2024-516364-28-00 Prevention of Group B streptoccoccus infection 2025-03-07
Phase 2/3 Randomized Study of INBRX-106 Add-on to Pembrolizumab in First-Line PD-L1 CPS ≥20 R/M HNSCC (HexAgon-HN) Ended

2024-515538-34-00 Head and Neck Squamous Cell Carcinoma 2025-02-27
Preemptive treatment with venetoclax plus azacitidine in patients diagnosed with acute myeloid leukemia (AML) with persistence or reappearan… Ended

2024-510648-29-00 Patients diagnosed with acute myeloid leukemia (AML) wi 2024-12-12
REBALANCE UC : impact of Fecal Microbiota Transplantation in ulcerative colitis:a randomized, sham controlled trial Ended

2024-511863-27-01 Adult patients with ulcerative colitis diagnosed for at 2024-12-06
A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF (in patients with Diabetic Macular Edema… Ended

2024-510944-30-00 Diabetic Macular Edema 2024-11-22
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination with Intravenously… Ended

2024-512147-23-00 Chronic Lymphocytic Leukemia 2024-11-21
Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP) Ended

2023-507891-31-00 Human Immunodeficiency Virus (HIV-1) infection 2024-10-11
LCH-IV International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis Ended

2024-512676-36-00 Langerhans Cell Histiocytosis 2024-10-09